Gene · 84295
Papers1,520
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,520
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retrospective analysis of clinical and molecular characteristics as prognostic factors in adult T-cell lymphoblastic lymphoma. | Am J Cancer Res | 2024 | 39803658 | PubTator, text mining | PubMed |
| The structure of a Tau fragment bound to tubulin prompts new hypotheses on Tau mechanism and oligomerization. | PNAS Nexus | 2024 | 39534653 | PubTator, text mining | PubMed |
| Harnessing the prognostic potential of PHF6 mutations in chronic myelomonocytic leukemia. | Am J Hematol | 2024 | 39470272 | PubTator, text mining | PubMed |
| Prognostic impact of next-generation sequencing on myelodysplastic syndrome: A single-center experience. | Medicine (Baltimore) | 2024 | 39465815 | PubTator, text mining | PubMed |
| Loss of PHF6 causes spontaneous seizures, enlarged brain ventricles and altered transcription in the cortex of a mouse model of the Börjeson-Forssman-Lehmann intellectual disability syndrome. | PLoS Genet | 2024 | 39405291 | PubTator, text mining | PubMed |
| Disruption of PHF6 Peptide Aggregation from Tau Protein: Mechanisms of Palmatine Chloride in Preventing Early PHF6 Aggregation. | ACS Chem Neurosci | 2024 | 39404232 | PubTator, text mining | PubMed |
| PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis. | Am J Hematol | 2024 | 39329442 | PubTator, text mining | PubMed |
| [Analysis of Factors Influencing Overall Survival and Prognosis of AML Patients Over 50 Years Old]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39192395 | PubTator, text mining | PubMed |
| PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression. | Nat Commun | 2024 | 39181868 | PubTator, text mining | PubMed |
| PHF6 suppresses self-renewal of leukemic stem cells in AML. | Leukemia | 2024 | 39004675 | PubTator, text mining | PubMed |
| PICALM::MLLT10 may indicate a new subgroup of acute leukemias with miscellaneous immunophenotype and poor initial treatment response but showing sensitivity to venetoclax. | EJHaem | 2024 | 38895061 | PubTator, text mining | PubMed |
| NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients. | Blood | 2024 | 38848537 | PubTator, text mining | PubMed |
| The detection of a strong episignature for Chung-Jansen syndrome, partially overlapping with Börjeson-Forssman-Lehmann and White-Kernohan syndromes. | Hum Genet | 2024 | 38787418 | PubTator, text mining | PubMed |
| Precision proteoform design for 4R tau isoform selective templated aggregation. | Proc Natl Acad Sci U S A | 2024 | 38568974 | PubTator, text mining | PubMed |
| Exploring the Aggregation Propensity of PHF6 Peptide Segments of the Tau Protein Using Ion Mobility Mass Spectrometry Techniques. | Anal Chem | 2024 | 38517679 | PubTator, text mining | PubMed |
| Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity. | Eur J Med Chem | 2024 | 38490063 | PubTator, text mining | PubMed |
| A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered protein. | J Biol Chem | 2024 | 38484799 | PubTator, text mining | PubMed |
| Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center. | BMC Cancer | 2024 | 38459434 | PubTator, text mining | PubMed |
| PHF6-mediated transcriptional control of NSC via Ephrin receptors is impaired in the intellectual disability syndrome BFLS. | EMBO Rep | 2024 | 38429579 | PubTator, text mining | PubMed |
| Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion. | Leukemia | 2024 | 38429501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84295/papers?page=5